Australian Government subsidy of Continuous Glucose Monitors 23 December 2016 During the 2016 Federal Election, the Government committed to subsidise continuous glucose monitoring (CGM) technology to assist children and young adults under 21 years of age who face extra challenges managing their type 1 diabetes. The Government, through the Department of Health, is working to address this election commitment. While this work is well advanced, a commencement date has not been determined. The Department of Health is consulting with Diabetes Australia, expert endocrinologists and clinicians and other key stakeholders to assist with the implementation of this commitment as part of the National Diabetes Services Scheme (NDSS) and to ensure that eligible children and young adults receive the support they need. Work is continuing to finalise elements such as the clinical eligibility criteria, authorisation process, supply arrangements, information, education and support programs as well as the administrative and information technology systems changes required to implement this commitment. Further information will be provided once these details have been finalised.
News 19 January 2026 National Diabetes Summit to convene at Federal Parliament Australia’s response to one of its most significant health challenges will come into sharp focus at Diabetes Australia’s National Diabetes... Continue Reading
News 16 January 2026 Wegovy to be listed on PBS The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended Wegovy (semaglutide) be subsidised through the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease and obesity. Diabetes Australia’s Group CEO... Continue Reading
Blog 15 January 2026 Five signs it’s time to book a diabetes telehealth appointment Accessing telehealth can be useful if you are newly diagnosed, you feel unwell, or if you are navigating a life transition. Continue Reading